Luis Caveda has a Pharmacy Degree from the Medical University of Szeged in Hungary and a Doctorate (PhD.) Degree in Biology from the University of Havana.
In 2019, Luis joined the Axogen team after serving as Senior Director of Regulatory Affairs of Rockwell Medical Inc. Previously he was the Regulatory Head of Pharma Bio-Serv a Consulting Company with a global presence.
In 2011 he founded the company Caveda Consulting, specializing in consulting programs in human and animal health in Latin America and Europe. He is considered a world expert in development of new drugs to treat vascular diseases and cancer. Previously he served as Executive Vice President of Thrombotargets Group in Spain and North Carolina, USA and Vice President of Pharmaceutical Development and Regulatory Affairs in ViviaBiotech SL in Madrid, specializing in the preclinical and clinical development of new molecules (chemical and biological) and in regulatory affairs in connection with medicine agencies (FDA and EMA).